Rely on an extensive portfolio of tailored TaqPath COVID-19 testing solutions to meet your needs as they evolve
The US Food and Drug Administration (FDA) authorized the Applied Biosystems TaqPath COVID-19 Kit for emergency use just days after the World Health Organization (WHO) declared COVID-19 a global pandemic and later received the CE mark in Europe. Since then, Thermo Fisher Scientific has continued to grow and enhance the TaqPath testing portfolio, enabling an uninterrupted product supply to support your lab’s evolving needs—now and in the future.
Note: This tool is best viewed in Chrome, Firefox or Safari Browsers. Learn more ›
We are a trusted partner during this time, enabling unprecedented testing demand and providing accurate, proven results.
TaqPath COVID-19 Combo Kit, Amplitude Solution, TaqPath COVID-19, Flu A, Flu B Combo Kit, TaqPath COVID-19 Pooling kit, TaqPath COVID-19 Fast PCR Combo Kit 2.0, and TaqPath COVID-19 RNase P Combo Kit 2.0: For Emergency Use Authorization (EUA) only. For prescription use only. For in vitro diagnostic use.